CORBION NV (CRBN.AS) Fundamental Analysis & Valuation

AMS:CRBN • NL0010583399

Current stock price

18.71 EUR
-0.3 (-1.58%)
Last:

This CRBN.AS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. CRBN.AS Profitability Analysis

1.1 Basic Checks

  • CRBN had positive earnings in the past year.
  • In the past year CRBN had a positive cash flow from operations.
  • In the past 5 years CRBN has always been profitable.
  • In the past 5 years CRBN always reported a positive cash flow from operatings.
CRBN.AS Yearly Net Income VS EBIT VS OCF VS FCFCRBN.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M

1.2 Ratios

  • CRBN has a better Return On Assets (5.28%) than 69.57% of its industry peers.
  • With a decent Return On Equity value of 10.07%, CRBN is doing good in the industry, outperforming 65.22% of the companies in the same industry.
  • Looking at the Return On Invested Capital, with a value of 8.67%, CRBN is in the better half of the industry, outperforming 73.91% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for CRBN is in line with the industry average of 7.00%.
  • The last Return On Invested Capital (8.67%) for CRBN is above the 3 year average (6.40%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 5.28%
ROE 10.07%
ROIC 8.67%
ROA(3y)7.34%
ROA(5y)6.63%
ROE(3y)15.47%
ROE(5y)14.99%
ROIC(3y)6.4%
ROIC(5y)6.39%
CRBN.AS Yearly ROA, ROE, ROICCRBN.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

1.3 Margins

  • With a decent Profit Margin value of 5.90%, CRBN is doing good in the industry, outperforming 63.77% of the companies in the same industry.
  • CRBN's Profit Margin has declined in the last couple of years.
  • CRBN has a Operating Margin of 9.97%. This is in the better half of the industry: CRBN outperforms 63.77% of its industry peers.
  • In the last couple of years the Operating Margin of CRBN has remained more or less at the same level.
  • Looking at the Gross Margin, with a value of 26.41%, CRBN is in line with its industry, outperforming 42.03% of the companies in the same industry.
  • In the last couple of years the Gross Margin of CRBN has remained more or less at the same level.
Industry RankSector Rank
OM 9.97%
PM (TTM) 5.9%
GM 26.41%
OM growth 3Y10.27%
OM growth 5Y-0.1%
PM growth 3Y-1.49%
PM growth 5Y-4.45%
GM growth 3Y5.66%
GM growth 5Y-1.14%
CRBN.AS Yearly Profit, Operating, Gross MarginsCRBN.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

5

2. CRBN.AS Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CRBN is creating some value.
  • CRBN has less shares outstanding than it did 1 year ago.
  • The number of shares outstanding for CRBN has been reduced compared to 5 years ago.
  • The debt/assets ratio for CRBN has been reduced compared to a year ago.
CRBN.AS Yearly Shares OutstandingCRBN.AS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M
CRBN.AS Yearly Total Debt VS Total AssetsCRBN.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

2.2 Solvency

  • CRBN has a debt to FCF ratio of 4.82. This is a neutral value as CRBN would need 4.82 years to pay back of all of its debts.
  • CRBN's Debt to FCF ratio of 4.82 is fine compared to the rest of the industry. CRBN outperforms 68.12% of its industry peers.
  • CRBN has a Debt/Equity ratio of 0.47. This is a healthy value indicating a solid balance between debt and equity.
  • CRBN has a Debt to Equity ratio (0.47) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF 4.82
Altman-Z N/A
ROIC/WACC1.43
WACC6.04%
CRBN.AS Yearly LT Debt VS Equity VS FCFCRBN.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M

2.3 Liquidity

  • A Current Ratio of 1.89 indicates that CRBN should not have too much problems paying its short term obligations.
  • CRBN's Current ratio of 1.89 is in line compared to the rest of the industry. CRBN outperforms 56.52% of its industry peers.
  • CRBN has a Quick Ratio of 1.11. This is a normal value and indicates that CRBN is financially healthy and should not expect problems in meeting its short term obligations.
  • CRBN has a Quick ratio (1.11) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.89
Quick Ratio 1.11
CRBN.AS Yearly Current Assets VS Current LiabilitesCRBN.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

3

3. CRBN.AS Growth Analysis

3.1 Past

  • The earnings per share for CRBN have decreased strongly by -60.30% in the last year.
  • The Earnings Per Share has been growing slightly by 0.98% on average over the past years.
  • Looking at the last year, CRBN shows a decrease in Revenue. The Revenue has decreased by -1.61% in the last year.
  • Measured over the past years, CRBN shows a small growth in Revenue. The Revenue has been growing by 5.14% on average per year.
EPS 1Y (TTM)-60.3%
EPS 3Y-5.44%
EPS 5Y0.98%
EPS Q2Q%44.62%
Revenue 1Y (TTM)-1.61%
Revenue growth 3Y-4.56%
Revenue growth 5Y5.14%
Sales Q2Q%-4.49%

3.2 Future

  • Based on estimates for the next years, CRBN will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.65% on average per year.
  • The Revenue is expected to grow by 2.88% on average over the next years.
EPS Next Y11.51%
EPS Next 2Y11.86%
EPS Next 3Y9.65%
EPS Next 5YN/A
Revenue Next Year1.7%
Revenue Next 2Y2.74%
Revenue Next 3Y2.88%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CRBN.AS Yearly Revenue VS EstimatesCRBN.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B
CRBN.AS Yearly EPS VS EstimatesCRBN.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.5 1 1.5

6

4. CRBN.AS Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 14.50, which indicates a correct valuation of CRBN.
  • CRBN's Price/Earnings ratio is a bit cheaper when compared to the industry. CRBN is cheaper than 76.81% of the companies in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 26.17, CRBN is valued a bit cheaper.
  • A Price/Forward Earnings ratio of 12.16 indicates a correct valuation of CRBN.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of CRBN indicates a somewhat cheap valuation: CRBN is cheaper than 78.26% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 23.05, CRBN is valued a bit cheaper.
Industry RankSector Rank
PE 14.5
Fwd PE 12.16
CRBN.AS Price Earnings VS Forward Price EarningsCRBN.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • CRBN's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. CRBN is cheaper than 72.46% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, CRBN is valued cheaper than 85.51% of the companies in the same industry.
Industry RankSector Rank
P/FCF 11.76
EV/EBITDA 7.03
CRBN.AS Per share dataCRBN.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

  • CRBN's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • The decent profitability rating of CRBN may justify a higher PE ratio.
PEG (NY)1.26
PEG (5Y)14.82
EPS Next 2Y11.86%
EPS Next 3Y9.65%

6

5. CRBN.AS Dividend Analysis

5.1 Amount

  • CRBN has a Yearly Dividend Yield of 3.44%. Purely for dividend investing, there may be better candidates out there.
  • CRBN's Dividend Yield is a higher than the industry average which is at 2.35.
  • CRBN's Dividend Yield is rather good when compared to the S&P500 average which is at 1.89.
Industry RankSector Rank
Dividend Yield 3.44%

5.2 History

  • The dividend of CRBN has a limited annual growth rate of 2.76%.
Dividend Growth(5Y)2.76%
Div Incr Years0
Div Non Decr Years1
CRBN.AS Yearly Dividends per shareCRBN.AS Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 2026 0.2 0.4 0.6

5.3 Sustainability

  • CRBN pays out 49.73% of its income as dividend. This is a bit on the high side, but may be sustainable.
  • CRBN's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP49.73%
EPS Next 2Y11.86%
EPS Next 3Y9.65%
CRBN.AS Yearly Income VS Free CF VS DividendCRBN.AS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M
CRBN.AS Dividend Payout.CRBN.AS Dividend Payout, showing the Payout Ratio.CRBN.AS Dividend Payout.PayoutRetained Earnings

CRBN.AS Fundamentals: All Metrics, Ratios and Statistics

CORBION NV

AMS:CRBN (4/2/2026, 7:00:00 PM)

18.71

-0.3 (-1.58%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)02-26
Earnings (Next)N/A
Inst Owners91.96%
Inst Owner ChangeN/A
Ins Owners0.22%
Ins Owner ChangeN/A
Market Cap1.09B
Revenue(TTM)1.27B
Net Income(TTM)74.80M
Analysts78.57
Price Target23.74 (26.88%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.44%
Yearly Dividend0.64
Dividend Growth(5Y)2.76%
DP49.73%
Div Incr Years0
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.59%
PT rev (3m)-0.75%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)1.11%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.08%
Revenue NY rev (3m)-0.75%
Valuation
Industry RankSector Rank
PE 14.5
Fwd PE 12.16
P/S 0.86
P/FCF 11.76
P/OCF 6.77
P/B 1.47
P/tB 1.67
EV/EBITDA 7.03
EPS(TTM)1.29
EY6.89%
EPS(NY)1.54
Fwd EY8.22%
FCF(TTM)1.59
FCFY8.51%
OCF(TTM)2.76
OCFY14.76%
SpS21.76
BVpS12.75
TBVpS11.22
PEG (NY)1.26
PEG (5Y)14.82
Graham Number19.24
Profitability
Industry RankSector Rank
ROA 5.28%
ROE 10.07%
ROCE 11.38%
ROIC 8.67%
ROICexc 9.03%
ROICexgc 9.85%
OM 9.97%
PM (TTM) 5.9%
GM 26.41%
FCFM 7.31%
ROA(3y)7.34%
ROA(5y)6.63%
ROE(3y)15.47%
ROE(5y)14.99%
ROIC(3y)6.4%
ROIC(5y)6.39%
ROICexc(3y)6.72%
ROICexc(5y)6.85%
ROICexgc(3y)7.49%
ROICexgc(5y)7.87%
ROCE(3y)8.41%
ROCE(5y)8.39%
ROICexgc growth 3Y-0.2%
ROICexgc growth 5Y-5.63%
ROICexc growth 3Y2.91%
ROICexc growth 5Y-2.42%
OM growth 3Y10.27%
OM growth 5Y-0.1%
PM growth 3Y-1.49%
PM growth 5Y-4.45%
GM growth 3Y5.66%
GM growth 5Y-1.14%
F-Score7
Asset Turnover0.89
Health
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF 4.82
Debt/EBITDA 1.64
Cap/Depr 79.49%
Cap/Sales 5.38%
Interest Coverage 8.21
Cash Conversion 75.82%
Profit Quality 123.93%
Current Ratio 1.89
Quick Ratio 1.11
Altman-Z N/A
F-Score7
WACC6.04%
ROIC/WACC1.43
Cap/Depr(3y)117.66%
Cap/Depr(5y)178.72%
Cap/Sales(3y)7.91%
Cap/Sales(5y)10.76%
Profit Quality(3y)66%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-60.3%
EPS 3Y-5.44%
EPS 5Y0.98%
EPS Q2Q%44.62%
EPS Next Y11.51%
EPS Next 2Y11.86%
EPS Next 3Y9.65%
EPS Next 5YN/A
Revenue 1Y (TTM)-1.61%
Revenue growth 3Y-4.56%
Revenue growth 5Y5.14%
Sales Q2Q%-4.49%
Revenue Next Year1.7%
Revenue Next 2Y2.74%
Revenue Next 3Y2.88%
Revenue Next 5YN/A
EBIT growth 1Y39.36%
EBIT growth 3Y5.24%
EBIT growth 5Y5.03%
EBIT Next Year80.79%
EBIT Next 3Y26.02%
EBIT Next 5YN/A
FCF growth 1Y-7.21%
FCF growth 3YN/A
FCF growth 5Y35.76%
OCF growth 1Y-12.6%
OCF growth 3Y60.39%
OCF growth 5Y8.1%

CORBION NV / CRBN.AS Fundamental Analysis FAQ

What is the fundamental rating for CRBN stock?

ChartMill assigns a fundamental rating of 5 / 10 to CRBN.AS.


What is the valuation status for CRBN stock?

ChartMill assigns a valuation rating of 6 / 10 to CORBION NV (CRBN.AS). This can be considered as Fairly Valued.


How profitable is CORBION NV (CRBN.AS) stock?

CORBION NV (CRBN.AS) has a profitability rating of 6 / 10.


What are the PE and PB ratios of CORBION NV (CRBN.AS) stock?

The Price/Earnings (PE) ratio for CORBION NV (CRBN.AS) is 14.5 and the Price/Book (PB) ratio is 1.47.


How financially healthy is CORBION NV?

The financial health rating of CORBION NV (CRBN.AS) is 5 / 10.